Adc Therapeutics Sa Share Price (NYSE: ADCT)
$3.08
Last updated on
Check the interactive Adc Therapeutics Sa Stock chart to analyse performance
Adc Therapeutics Sa stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$3.08Today's High:$3.21
0.0%
Downside
Day's Volatility :4.05%
Upside
4.05%
- 52 Weeks Low:$1.0552 Weeks High:$3.97
65.91%
Downside
52 Weeks Volatility :73.55%
Upside
22.42%
Adc Therapeutics Sa Stock Returns
Adc Therapeutics Sa Key Stats
Check Adc Therapeutics Sa key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Adc Therapeutics Sa Stock including INR - Dollar returns
The Adc Therapeutics Sa stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Adc Therapeutics Sa investment value today
Current value as on today
₹1,18,105
Returns
₹18,105
(+18.1%)
Returns from Adc Therapeutics Sa Stock
₹12,821 (+12.82%)
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Adc Therapeutics Sa Stock
Global Institutional Holdings in Adc Therapeutics Sa
Name
Holdings %
Redmile Group, LLC
13.93%
Prosight Management, LP
8.48%
Point72 Asset Management, L.P.
6.90%
Orbimed Advisors, LLC
5.31%
BlackRock Inc
4.37%
Morgan Stanley - Brokerage Accounts
2.68%
Analyst Recommendation on Adc Therapeutics Sa Stock
Buy
83%Buy
16%Hold
0%Sell
Based on 12 Wall street analysts offering stock ratings for Adc Therapeutics Sa(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Adc Therapeutics Sa Share Price Target
What analysts predicted
Upside of 166.23%
Target:
$8.20
Current:
$3.08
Adc Therapeutics Sa share price target is $8.20, a slight Upside of 166.23% compared to current price of $3.08 as per analysts' prediction.
Adc Therapeutics Sa Stock Insights
Price Movement
In the last 6 months, ADCT stock has moved up by 74.4%Decreasing Revenue
Revenue is down for the last 2 quarters, 23.03M → 18.83M (in $), with an average decrease of 18.2% per quarterDecreasing Net Profit
Netprofit is down for the last 3 quarters, -30.72M → -56.64M (in $), with an average decrease of 36.2% per quarterADCT vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 64.0%ADCT vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 171.0%Price to Sales
ForADCT every $1 of sales, investors are willing to pay $4.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Adc Therapeutics Sa Financials
Adc Therapeutics Sa Technicals Summary
Sell
Neutral
Buy
Adc Therapeutics Sa is currently in a neutral trading position according to technical analysis indicators.
Adc Therapeutics Sa Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 14.13% | 93.08% | 12.45% | -54.72% | -92.55% |
 | 3.92% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 2.49% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -15.42% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 11.08% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -1.53 | -7.06 | -0.23 | NA | -1.77 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $345.4M | -92.55% | NA | -220.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Adc Therapeutics Sa
Key Management of Adc Therapeutics Sa
Important FAQs about investing in ADCT Stock from India :
What is Adc Therapeutics Sa share price today?
Adc Therapeutics Sa share price today is $3.08 as on at the close of the market. Adc Therapeutics Sa share today touched a day high of $3.21 and a low of $3.08.
What is the 52 week high and 52 week low for Adc Therapeutics Sa share?
Adc Therapeutics Sa share touched a 52 week high of $3.97 and a 52 week low of $1.05. Adc Therapeutics Sa stock price today i.e. is closed at $3.08, lower by 22.42% versus the 52 week high.
How to invest in Adc Therapeutics Sa Stock (ADCT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Adc Therapeutics Sa on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adc Therapeutics Sa Shares that will get you 0.4870 shares as per Adc Therapeutics Sa share price of $3.08 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Adc Therapeutics Sa Stock (ADCT) from India?
Indian investors can start investing in Adc Therapeutics Sa (ADCT) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Adc Therapeutics Sa stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Adc Therapeutics Sa share’s latest price of $3.08 as on August 30, 2025 at 1:29 am IST, you will get 3.2468 shares of Adc Therapeutics Sa. Learn more about
fractional shares .
What are the returns that Adc Therapeutics Sa has given to Indian investors in the last 5 years?
Adc Therapeutics Sa stock has given -92.55% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%